Fortress Biotech (FBIO) Dividends Paid - Common (2020 - 2025)
Fortress Biotech (FBIO) posted quarterly Dividends Paid - Common of $166000.0 for Q4 2025, little changed year-over-year from $166000.0 in Q4 2024, and little changed quarter-over-quarter from $166000.0 in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Dividends Paid - Common (2020 - 2025) Analysis & Trends
Fortress Biotech's Dividends Paid - Common history runs 6 years deep, the most recent figure standing at $166000.0 for Q4 2025.
- In Q4 2025, Dividends Paid - Common changed 0.0% year-over-year to $166000.0; the TTM figure through Dec 2025 stood at $664000.0 (down 4.32% YoY), while the FY2025 annual figure was $664000.0, down 4.32% from the prior year.
- Dividends Paid - Common for Q4 2025 stood at $166000.0, roughly flat from $166000.0 in the prior quarter.
- The five-year high for Dividends Paid - Common was $188000.0 in Q2 2021, with the low at $166000.0 in Q4 2024.
- The 5-year median for Dividends Paid - Common is $185000.0 (2023), against an average of $179600.0.
- The sharpest annual moves came in 2021 and 2024: Dividends Paid - Common soared 274.0% in 2021, then dropped 7.78% in 2024.
- Fortress Biotech's Dividends Paid - Common stood at $187000.0 in 2021, then slipped by 0.53% to $186000.0 in 2022, then dropped by 3.23% to $180000.0 in 2023, then fell by 7.78% to $166000.0 in 2024, then changed by 0.0% to $166000.0 in 2025.
- Business Quant data shows FBIO's Dividends Paid - Common at $166000.0 in Q4 2025, $166000.0 in Q3 2025, and $166000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 34.60 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | - |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 166,000.00 |
| Sep 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Mar 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 166,000.00 |
| Sep 30, 2024 | 176,000.00 |
| Jun 30, 2024 | 176,000.00 |
| Mar 31, 2024 | 176,000.00 |
| Dec 31, 2023 | 180,000.00 |
| Sep 30, 2023 | 185,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | 186,000.00 |
| Dec 31, 2022 | 186,000.00 |
| Sep 30, 2022 | 188,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 187,000.00 |
| Dec 31, 2021 | 187,000.00 |
| Sep 30, 2021 | 187,000.00 |
| Jun 30, 2021 | 188,000.00 |
| Mar 31, 2021 | 187,000.00 |